Focus Partners Advisor Solutions LLC Invests $1.29 Million in McKesson Corporation $MCK

Key Points

• Focus Partners Advisor Solutions acquired 1,702 McKesson shares worth approximately $1.29 million in the second quarter. Institutional investors collectively own 85.07% of the company.
• Analysts maintain a positive outlook, with 14 Buy ratings and three Holds, producing a “Moderate Buy” consensus and an average price target of $977. TD Cowen and Citigroup recently raised their targets above $1,000.
• McKesson exceeded quarterly expectations, reporting $9.93 in EPS and $105.38 billion in revenue, while revenue grew 7.7% year over year. The company also raised its quarterly dividend from $0.82 to $0.94 per share.

Focus Partners Advisor Solutions LLC acquired a new stake in shares of McKesson Corporation (NYSE:MCK - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,702 shares of the company's stock, valued at approximately $1,286,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of MCK. University of Texas Texas AM Investment Management Co. purchased a new position in McKesson during the fourth quarter valued at $25,000. Swiss RE Ltd. purchased a new stake in McKesson in the fourth quarter worth about $26,000. State of Wyoming purchased a new stake in McKesson in the second quarter worth about $29,000. Kingdom Financial Group LLC. bought a new position in shares of McKesson in the fourth quarter worth about $33,000. Finally, Birchwood Financial Partners Inc. bought a new position in shares of McKesson in the fourth quarter worth about $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Weiss Ratings downgraded McKesson from a "buy (b)" rating to a "buy (b-)" rating in a research note on Tuesday, July 7th. Morgan Stanley restated an "overweight" rating on shares of McKesson in a research note on Friday, August 7th. William Blair started coverage on shares of McKesson in a report on Tuesday, April 28th. They set an "outperform" rating on the stock. TD Cowen increased their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Finally, Citigroup increased their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Friday, July 24th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, McKesson presently has an average rating of "Moderate Buy" and an average price target of $977.00.

McKesson Trading Down 0.0%

Shares of MCK opened at $868.72 on Monday. The business's 50 day moving average is $813.45 and its 200 day moving average is $842.94. The company has a market capitalization of $101.28 billion, a PE ratio of 23.25, a price-to-earnings-growth ratio of 1.71 and a beta of 0.30. McKesson Corporation has a 12-month low of $667.50 and a 12-month high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping analysts' consensus estimates of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The company had revenue of $105.38 billion for the quarter, compared to analysts' expectations of $103.88 billion. During the same period in the previous year, the firm earned $8.26 EPS. The firm's revenue was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Equities research analysts predict that McKesson Corporation will post 44.65 earnings per share for the current year.

McKesson Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be issued a $0.94 dividend. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. This is a boost from McKesson's previous quarterly dividend of $0.82. The ex-dividend date of this dividend is Tuesday, September 1st. McKesson's payout ratio is presently 8.78%.

Insider Activity

In related news, EVP Michele Lau sold 3,550 shares of the company's stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at approximately $2,471,259.23. This represents a 52.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the firm's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 29,049 shares of company stock valued at $22,530,626 in the last quarter. Company insiders own 0.06% of the company's stock.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source